Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CTI BioPharma Corp. (NASDAQ: CTIC) to Swedish Orphan Biovitrum AB for $9.10 per share is fair to CTI BioPharma shareholders. Halper Sadeh encourages CTI BioPharma shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
[email protected] or
[email protected] . The investigation concerns whether CTI BioPharma and its...